Table 1.
Characteristics of patients who underwent pancreatectomy with simultaneous hepatectomy compared with those who underwent isolated hepatectomy for synchronous or metachronous metastases
| Simultaneous hepatectomy (n = 131) | Isolated hepatectomy (n = 74) | p-value | |
|---|---|---|---|
| Age (years) | 56 (45–64) | 57 (50–63) | 0.62 |
| Female sex | 59 (45%) | 36 (49%) | 0.72 |
| White racea | 120 (93%) | 70 (96%) | 0.54 |
| Charlson Comorbidity Index | 7 (6–8) | 8 (7–8) | 0.14 |
| Functional tumor | 26 (20%) | 12 (16%) | 0.65 |
| Hereditary cancer syndrome | 10 (7.6%) | 7 (13%) | 0.39 |
| Ki-67 ≥3%a | 58 (84%) | 24 (71%) | 0.18 |
| Overall grade ≥2a | 86 (76%) | 45 (67%) | 0.26 |
| 10+ liver metastases | 71 (54%) | 25 (34%) | 0.008 |
| Largest liver lesion (mm) | 42 (22–65) | 34 (19–61) | 0.26 |
| Extrahepatic disease | 11 (8.4%) | 6 (8.1%) | 0.99 |
| Follow-up (months) | 48 (24–97) | 57 (19–118) | 0.81 |
Categorical variables are shown as number (percentage) and continuous variables as median (interquartile range)
aPatients with missing information on race (n = 3), Ki-67 (n = 102), and grade (n = 25) were excluded from the respective analyses.